EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis

Abigail L Pfaff, Vivien J Bubb, John P Quinn, Sulev Kõks

Experimental Biology and Medicine · 2025

DOI: 10.3389/ebm.2025.10600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2025. Verfasst von Abigail L Pfaff und 3 weiteren Autor:innen. Beteiligte Einrichtung: Perron Institute for Neurological and Translational Science, Perth, WA, Australia. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Minisatellite Repeats, Short Interspersed Nucleotide Elements. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The fatal neurodegenerative disease, amyotrophic lateral sclerosis (ALS), leads to the degeneration of motor neurons in the brain and spinal cord. Many different genetic variants are known to increase the risk of developing ALS, however much of the disease heritability is still to be identified. To identify novel genetic factors, we characterised SINE-VNTR-Alu (SVA) presence/absence variation in 4403 genomes from the New York Genome Center (NYGC) ALS consortium. SVAs are a type of retrotransposon able to mobilise in the human genome generating new insertions that can modulate gene expression and mRNA splicing and to date 33 insertions are known to cause a range of genetic diseases. In the NYGC ALS consortium sequence data 2831 non-reference genome SVAs were identified and 95% of these insertions were rare with an insertion allele frequency of less than 0.01. Association analysis of the common SVAs with ALS risk, age at onset and survival did not identify any SVAs that survived correction for multiple testing. However, there were three different rare SVA insertions in the ALS associated gene NEK1 identified in four different individuals with ALS. The frequency of these rare insertions in NEK1 was significantly higher in the individuals with ALS from the NYGC ALS consortium compared to the gnomAD SV non-neuro controls (p = 0.0002). This study was the first to characterise non-reference SVA presence/absence variation in a large cohort of ALS individuals identifying insertions as potential candidates involved in disease development for further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisMinisatellite RepeatsShort Interspersed Nucleotide ElementsHumansGenetic Predisposition to DiseaseMaleFemaleMiddle AgedGene Frequency

Stichwörter der Autor:innen

SVAamyotrophic lateral sclerosisgeneticsneurodegenerationretrotransposons

Autor:innen und Institutionen

  • Perron Institute for Neurological and Translational Science, Perth, WA, Australia.
  • Personalised Medicine Centre, Health Futures Institute, Murdoch University, Perth, WA, Australia.
  • Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.

Zitieren

APA

Pfaff, A. L., Bubb, V. J., Quinn, J. P., & Kõks, S. (2025). The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2025.10600

Vancouver

Pfaff AL, Bubb VJ, Quinn JP, Kõks S. The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis. Experimental Biology and Medicine. 2025. doi:10.3389/ebm.2025.10600

BibTeX
@article{Pfaff2025,
  author = {Pfaff, Abigail L and Bubb, Vivien J and Quinn, John P and Kõks, Sulev},
  title = {The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis},
  journal = {Experimental Biology and Medicine},
  year = {2025},
  doi = {10.3389/ebm.2025.10600}
}
Kostenlos starten →